Cognitive decline in cancer: A cross-sectional study
- Conditions
- cancercancer-related cognitive impairment (CRCI)cancer psychosocial distressneurodegenerative disordersNeurological - Neurodegenerative diseasesCancer - Any cancer
- Registration Number
- ACTRN12622001537741
- Lead Sponsor
- Curtin University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Study inclusion criteria require participants to be aged over 18 years old, currently live in Perth and Peel regions of Western Australia (or close enough), have been diagnosed with non-CNS cancer, be currently undergoing any treatment, and have a working proficiency of the English language.
To provide a comparative baseline across assessments, 20-25% of the sample will consist of healthy controls that meet all other inclusion/exclusion criteria but are cancer-naive and are not undergoing treatment.
Exclusion criteria preclude participation of individuals with premorbid developmental / cognitive dysfunction; premorbid neurodegenerative conditions; pregnancy; and central nervous system metastases.
Enrolment in other trials may be an exclusion criterion - case by case basis.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Verbal memory, as assessed by the Hopkins Verbal Learning Test-Revised (HVLT-R).[ Baseline.];Peripheral BDNF levels, as measured by plasma assays.[ Baseline.];Attention / executive functioning, as assessed by the Trail Making Test (TMT).[ Baseline.]
- Secondary Outcome Measures
Name Time Method